Godrej Agrovet Q1 FY27: Sales Up 9% to ₹2,855 Cr, Cattle Feed Volumes Up 15%, and One of the Driest Junes in a Century

General information and education, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Always consult a SEBI-registered adviser.

1 — At a Glance

Six businesses, one monsoon, and a quarter where the weather picked a favourite.

Consolidated sales came in at ₹2,855 Cr for the June 2026 quarter, up 9.2% from ₹2,614 Cr a year earlier. Operating Profit was ₹240 Cr against ₹270 Cr. PAT was ₹128 Cr versus ₹149 Cr, and EPS came in at ₹6.99 against ₹8.35.

Underneath, the segments went in opposite directions with real conviction. Animal Nutrition revenue rose 12.6% to ₹1,302 Cr with cattle feed volumes up 15%. Vegetable Oil revenue rose to ₹619 Cr from ₹499 Cr, with CPO realisations at ₹1,34,783 per MT against ₹1,14,079. Crop Care went the other way: segment revenue ₹349 Cr against ₹403 Cr, and segment result ₹75.6 Cr against ₹116.5 Cr. Management attributes the Crop Care decline to a significantly delayed monsoon and slower kharif sowing, describing it as one of the driest Junes in over a decade — and in the earnings call, one of the worst Junes in the last century with a 40% deficit.

Dairy revenue rose 11.4% to ₹465 Cr, and its segment result was negative ₹1.9 Cr against a positive ₹4.3 Cr. Management cites elevated milk procurement prices and war-led packaging inflation.

Elsewhere: average net working capital fell to 21 days from 31 a year ago, per the company’s own disclosure. Astec LifeSciences reached EBITDA breakeven against a ₹11 Cr EBITDA loss. And the finance chief who has signed these numbers for years has filed for early superannuation.

Which is a lot of moving parts for a company most people think just sells cattle feed. About that.

2 — Introduction

Godrej Agrovet Limited describes itself as a diversified, R&D-focused agri-business company aimed at improving the productivity of Indian farmers through products and services that increase crop and livestock yields. It holds leading market positions in animal feed, crop protection, oil palm, dairy, and poultry and processed foods. It operates 60+ manufacturing facilities across India.

Structurally, it is a holding arrangement as much as an operating one. Creamline Dairy Products Limited runs the Godrej Jersey dairy business in southern India, processing approximately 6 lakh litres of milk a day. Godrej Foods Limited, a wholly owned subsidiary, handles ready-to-cook chicken and frozen foods under Real Good Chicken and Yummiez. Astec LifeSciences does custom synthesis of agrochemical actives and exports to roughly 17 countries. A 50% joint venture, ACI Godrej Agrovet, runs feed in Bangladesh. ICRA’s July 2026 report puts GAVL’s holding in Creamline at 99.78%, Godrej Foods at 100%, and Astec at 67.03%.

The stake-consolidation has been recent and deliberate. In May 2025 the company completed acquisition of 47.38% of Creamline from that company’s promoter group, taking its holding to 99.32%; the balance 36.79% purchase during the June 2025 quarter cost ₹708.58 Cr, with a further 0.46% for ₹8.93 Cr in the September 2025 quarter. In July 2025 GAVL participated in Astec’s rights issue for ₹199.01 Cr.

Leadership has turned over too. Sunil Kataria took charge as CEO & MD effective September 1, 2025, on a five-year tenure, following Balram Yadav’s superannuation. Nadir Godrej retires as Chairman on August 13, 2026, with Burjis N. Godrej appointed Chairperson from August 14, 2026.

On strategy, the Q1 FY27 presentation opens with what the company itself calls a “structural reset focused on value creation” — streamlining a complex portfolio, building multiple pillars of growth in each business, and shifting away from a commodity mindset. Capital allocation is stated at ₹300–350 Cr a year, funded through internal accruals. Live Bird Trading, the company says, will be closed.

3 — Business Model: WTF Do They Even Do?

Six segments, and each one answers to a different god.

Animal Nutrition (46% of FY26 revenue) is the anchor: cattle, layer, broiler, shrimp and fish feed, from among India’s largest organised feed manufacturers. Volumes went from 14,75,144 tonnes in FY25 to 16,46,545 tonnes in FY26. FY26 brought Dhanalaxmi G, a premium cattle feed for high-yielding cattle, and Bypro Plus, a high-protein formulation. Management has guided EBIT per tonne at roughly ₹2,050–2,150, which is an unusually specific number for a business whose customers are cows.

Oil Palm (19%) is the largest domestic producer of crude palm oil and palm kernel oil, working with farmers across the crop lifecycle, with a Samadhan Centre network expanded to 24 centres in FY26. This is the segment where the company is visibly changing shape — management describes a structural shift from a pure upstream player to an integrated upstream-to-downstream business, with a specialty fats refinery expected to start ramp-up in September, aimed at B2B food-ingredient applications. Roughly 50% of plantations are in the juvenile 0–4 year stage, per management, productive from year four and peaking around year eight. The business is, essentially, waiting for its trees to grow up.

Dairy (15%) is Creamline and the Godrej Jersey brand, where value-added products moved from 42% of sales in Q1 FY26 to 49% in Q1 FY27. Two of its listed Q1 wins are a ₹20 badam flavoured milk that reached 24.5K outlets with a 42% repeat rate, and a 30g protein paneer at ₹99 that hit 200% of planned revenue.

Crop